HALO·40637H109·US·equity·Healthcare - Biotechnology-13D/G
HALO (HALOZYME THERAPEUTICS INC) is held by 227 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($857.3M), STATE STREET CORP ($319.1M), Invesco Ltd. ($259.3M). Net institutional sentiment: Mixed.
See how HALO's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer